Titre :
  • Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.
Auteur : Ribi, K ; Aldridge, J ; Phillips, K-A ; Thompson, A ; Harvey, Vernon ; Thürlimann, Beat ; Cardoso, Fatima ; Pagani, Olivia ; Coates, Alan ; Goldhirsch, Aron ; Price, Karen N. ; Gelber, R D ; Bernhard, Jürg ; BIG 1-98 Collaborative and International Breast Cancer Study Groups ; International Breast Cancer Study Group
Informations sur la publication : British Journal of Cancer, 106, 10, (page 1618-1625)
Statut de publication : Publié, 2012-05
Sujet CREF : Cancérologie
Mots-clés : Aromatase inhibitor
Breast cancer
Letrozole
Quality of life
Subjective cognitive function
Tamoxifen
Mots-clés MeSH : Aromatase Inhibitors -- adverse effects
Breast Neoplasms -- drug therapy -- pathology -- psychology
Cognition -- drug effects
Estrogen Antagonists -- adverse effects
Female
Humans
Neoplasm Staging
Nitriles -- adverse effects
Quality of Life
Tamoxifen -- adverse effects
Triazoles -- adverse effects
Note : Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0007-0920 
info:doi/10.1038/bjc.2012.156
info:pii/bjc2012156
info:pmid/22531635
info:pmcid/PMC3349183